Douglas Johnston
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Douglas Johnston
Douglas Johnston is recorded as CFO at Lipella Pharmaceuticals Inc. (LIPO). The proxy statement of Lipella Pharmaceuticals Inc. reports total compensation of $260,000 for Douglas Johnston in fiscal 2023, including a base salary of $165,000. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lipella Pharmaceuticals Inc.
Other people whose current roles at this company are on record from its filings.
- Jonathan Kaufman CEO, Board Member
- Daniel Cohen Board Member
- Dr. Lori Birder Board Member
- Lori Birder Board Member
- Ryan Pruchnic Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Lipella Pharmaceuticals Inc. (LIPO) | Chief Financial Officer | $165,000 | $260,000 |
| 2022 | Lipella Pharmaceuticals Inc. (LIPO) | Chief Financial Officer | $67,500 | $67,500 |
| 2021 | Lipella Pharmaceuticals Inc. (LIPO) | Chief Financial Officer | $12,000 | $12,000 |
Recent activity
No call appearances or filed executive changes recorded yet.